A. Lucendo

Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.

N. Barbarroja, M. Gahete, E. Collantes-Estévez, 2023, European journal of internal medicine.

Dupilumab demonstrated efficacy and was well tolerated regardless of prior use of swallowed topical corticosteroids in adolescent and adult patients with eosinophilic oesophagitis: a subgroup analysis of the phase 3 LIBERTY EoE TREET study

A. Bredenoord, I. Hirano, A. Shabbir, 2023, Gut.

Proton-Pump Inhibitors in Eosinophilic Esophagitis: A Review Focused on the Role of Pharmacogenetics

E. Laserna-Mendieta, L. Arias-González, P. Navarro, 2024, Pharmaceutics.

Fibrous Remodeling in Eosinophilic Esophagitis: Clinical Facts and Pathophysiological Uncertainties

E. Laserna-Mendieta, L. Arias-González, P. Navarro, 2024, International journal of molecular sciences.

Need for therapeutic escalation in patients with refractory ulcerative proctitis: Results from the PROCU study of the ENEIDA registry.

F. Mesonero, F. Argüelles-Arias, B. Sicilia, 2024, Alimentary pharmacology & therapeutics.

Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

F. Mesonero, M. Martín-Arranz, M. Casanova, 2024, Pharmaceutics.